Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations.


Patients with a family history of melanoma are at increased risk of this tumor. Those family members who also have the atypical mole syndrome are commonly targeted for screening in the belief that they are more likely to be mutant gene carriers. We have correlated the atypical mole syndrome phenotype and gene carrier status in five families with germline… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.